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Aims:Our aimwas to determinewhether alterations in biomechanical properties of humandiseased compared to
normal coronary artery contribute to changes in artery responsiveness to endothelin-1 in atherosclerosis.
Main methods: Concentration–response curves were constructed to endothelin-1 in normal and diseased
coronary artery. The passive mechanical properties of arteries were determined using tensile ring tests from
which ﬁnite element models of passive mechanical properties of both groups were created. Finite element
modelling of artery endothelin-1 responses was then performed.
Key ﬁndings:Maximum responses to endothelin-1were signiﬁcantly attenuated in diseased (27±3mN, n=55)
compared to normal (38 ± 2 mN, n = 68) artery, although this remained over 70% of control. There was no
difference in potency (pD2 control= 8.03± 0.06; pD2 diseased=7.98± 0.06). Finite elementmodelling of ten-
sile ring tests resulted in hyperelastic shearmodulus μ=2004±410 Pa and hardening exponentα=22.8±2.2
for normal wall and μ = 2464 ± 1075 Pa and α = 38.3 ± 6.7 for plaque tissue and distensibility of diseased
vessels was decreased. Finite element modelling of active properties of both groups resulted in higher muscle
contractile strain (represented by thermal reactivity) of the atherosclerotic artery model than the normal artery
model. The models suggest that a change in muscle response to endothelin-1 occurs in atherosclerotic artery to
increase its distensibility towards that seen in normal artery.
Signiﬁcance: Our data suggest that an adaptation occurs in medial smooth muscle of atherosclerotic coronary
artery to maintain distensibility of the vessel wall in the presence of endothelin-1. This may contribute to the
vasospastic effect of locally increased endothelin-1 production that is reported in this condition., Level 6 Add
ital, Cambr
uire).
icle under th© 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/ .0/).3Introduction
The endothelin (ET) system is up-regulated in human coronary
atherosclerosis with elevated levels of ET-1 detected in plasma
(Lerman et al. 1991), correlating to the extent of disease (Salomone
et al., 1996) and with increased ET-1 expression within the atheroscle-
rotic plaque (Zeiher et al., 1995; Bacon et al., 1996). Interestingly, in
response to this increased synthesis of ET peptide in human atheroscle-
rosis detected in vitro (Maguire and Davenport., 1998a; Ihling et al.,
2001) and in vivo (Böhmet al., 2002)we ﬁndno corresponding increase
in density of ET receptors in themedial smoothmuscle layer of coronary
artery and indeed there is a profound down-regulation of ET receptorenbrooke's Centre
idge CB2 0QQ, UK.
e CC BY-NC-ND license (expression in the non-contractile intimal smooth muscle layer (Bacon
et al., 1996; Maguire and Davenport, 2000; Katugampola et al., 2002).
Histological analysis of diseased coronary artery has demonstrated
marked atrophy of the contractile medial smooth muscle in the
remodelled arterial wall that is predicted to contribute to plaque
instability (Burke et al., 2002).
The mechanical properties of atherosclerotic artery have been
studied both in vitro (Beattie et al., 1998; Baldewsing et al., 2008) and
in vivo (van Popele et al., 2001; Baldewsing et al., 2008; Wykretowicz
et al., 2009), where the diseased artery has been shown to be stiffer
than healthy artery in clinical studies. Holzapfel and Ogden (2010)
have provided a review of the studies on the theoretical modelling of
arterial smooth muscle function. These include the study of Yang et al.
(2003) on a model integrating the electro- and mechano-chemical
functions of smooth muscle cell, as well as that of Zulliger et al. (2004)
on a pseudo-strain energy function describing the arterial mechanical
properties with the coupling of collagen, elastin, and smooth musclehttp://creativecommons.org/licenses/by-nc-nd/ .0/).3
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in these studies, the changes of arterial active properties with athero-
sclerotic disease remain unclear.
Our hypothesis was that the contractile responses to ET-1 in isolated
rings of human atherosclerotic coronary artery should be markedly
attenuated compared to histologically normal vessels. This should be a
consequence of the relative reduction in the amount of contractile
smooth muscle present, compounded by a decrease in arterial distensi-
bility resulting from gross changes in the vessel structure, particularly
intimal thickening, increased ﬁbrosis and the presence of lipid laden
and calciﬁed plaque (Stary et al., 1994, 1995). Our aim was to compare
contractile responses to ET-1 in human normal and atherosclerotic
coronary artery in vitro and to develop ﬁnite element (FE) models to
compare the passive and active mechanical properties of these vessels
in health and disease. We ﬁrst performed mechanical tests and FE
modelling to obtain the passive mechanical properties (stretch and
distensibility in response to mechanical loading in the absence of
chemically mediated smooth muscle cell activation) of both the normal
and diseased arteries. We then used these determined passive
properties in further FE modelling of the arterial active response to
ET-1 to understand how atherosclerosis-induced changes in arterial
structure and mechanical properties may affect this active response to
ET-1.
Unexpectedly we ﬁnd that compared to histologically normal
coronary artery, in vitro contractile responses to ET-1 are well
maintained in atherosclerotic vessels with FE modelling demonstrating
the capacity of medial smooth muscle cells in diseased arteries to
develop elevated contractile strains in response to ET-1 compared to
normal arteries.
Materials
Human tissue
Anonymised human coronary artery samples were used in this
study with local ethical approval (REC 05/Q0104/142). Samples
were obtained from Papworth Hospital Research Tissue Bank
(Cambridgeshire 1 Research Ethics Committee reference 08/H0304/
56) and were collected with written informed patient consent. Histo-
logically normal arteries (no visible evidence of atherosclerosis) were
from 68 patients transplanted for cardiomyopathies (Dec and Fuster,
1994) and atherosclerotic artery samples with evidence of coronary
artery disease (CAD, visible plaque present) were from 55 patients
transplanted for ischaemic heart disease. n-Values refer to the number
of patients from whom tissue was obtained. Artery samples for the
contractile functional experiments were transferred to the laboratory
in Krebs solution and used within 12 h of retrieval. ET-1 was purchased
from the Peptide Institute (Osaka, Japan). Stock solutions (10−4 M)
were made up in 0.1% acetic acid and stored at−70 °C. Krebs solution
was of the following composition: (mM) NaCl 90, KCl 5, MgS04.7H2O
0.5, Na2HPO4 1, NaHCO3 45, CaCl2 2.25, glucose 10, Na pyruvate 5,
fumaric acid 5, and L-glutamic acid 5.
Methods
Human coronary artery functional assay
Experiments were carried out as previously described (Maguire,
2002). Brieﬂy, 4 mm rings of histologically normal (n= 68) or athero-
sclerotic (n= 55) endothelium-denuded human coronary artery were
set up for isometric force recordings in 5 ml organ baths containing ox-
ygenated Krebs solution at 37 °C. For diseased arteries all 4 mm seg-
ments contained visible atherosclerotic plaque, although plaque size
was variable between samples. Following an active force normalisation
procedure to determine optimum resting force, successful removal of
the endothelium was conﬁrmed by lack of reversal of the contractileresponse to 10 μM phenylephrine by 1 μM acetylcholine. After 30 min-
ute equilibration, cumulative concentration–response curves (CRC)
were then constructed to ET-1 (10−10–10−6 M) and experiments
were completed by addition of 100 mM KCl to determine maximum
possible contractile response for each tissue. ET-1 responses were
expressed as force developed (mN) or % terminal KCl response. Data
were analysed using the non-linear iterative curve-ﬁtting programme
GraphPad Prism (GraphPad Software Inc., La Jolla, USA) to determine
values of pD2 (− log10 of the EC50 (the concentration of ET-1 that pro-
duces 50% of the maximum ET-1 response)) and maximum response
(EMAX).
Passive tensile ring tests
The passive mechanical properties of normal and atherosclerotic
human coronary arteries were determined using tensile ring tests. The
arterial samples were snap frozen to maintain structural integrity,
stored at -70 °C and defrosted before use. The defrosted samples were
expected to have negligible smooth muscle cell activation induced by
stretching. The artery rings were set up as above, uniaxial loadings
were applied to the rings and the reaction forces and arterial deforma-
tions in response to mechanical stretch were recorded in both normal
(n = 5) and atherosclerotic (n = 6) arterial rings. The mechanical
stretch λ of the ring was calculated as:
λ ¼ 2L
C
ð1Þ
where L is the distance between the twowires that were used to stretch
the arterial ring, and C is the inner circumference of the ring without
loading, which was measured from the histology image of the artery.
Finite element models of the passive mechanical properties of normal and
atherosclerotic coronary artery
For each normal artery sample the FE model was created using
Abaqus (Dassault Systèmes, Vélizy-Villacoublay, France), comprising a
single circular ring with diameter and wall thickness estimated from
the vessel histology (Fig. 1A). The models were assigned with ﬁrst
order Ogden hyperelastic properties with shear modulus μ and
hardening exponent α (Abaqus TheoryManual), assuming incompress-
iblematerial. Themodel reaction forceswerematchedwith those of the
corresponding tensile ring tests using an error minimisation approach
with MATLAB (MathWorks, Natick, USA) to determine the optimum μ
and α that provide the best matching. Mean values of μ and α of the
normal artery models were then calculated and expressed as mean ±
sem.
A similar approach was applied to the atherosclerotic artery models,
with an additional inner vessel wall layer included to represent plaque
tissue (Fig. 1B). For atherosclerotic artery the wall outer layer was
assigned with the same mean values of μ and α determined for normal
artery and the additional inner plaque layer was assignedwith different
optimum values of μ and α determined by matching the modelled
force–stretch results with those of the passive tensile ring tests for the
diseased artery samples.
In order to compare the overall stiffness of the normal and
atherosclerotic arteries, each of the FE models was loaded with internal
physiological pressures of 80mmHg and 120mmHg. The distensibility
D of each arterial samplewas determined from the geometry changes of
the model using Eq. (2):
D ¼ A120−A80
A80 P120−P80ð Þ
ð2Þ
where A80, A120, P80, and P120 are the lumen area A and pressure P at
80 mm Hg and 120 mm Hg, respectively. The stiffness of the arteries
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Fig. 1. Finite element models of rings of human normal and diseased coronary artery. (A) Normal and (B) atherosclerotic artery models for the tensile ring tests. (C) Normal and
(D) atherosclerotic artery models for the modelling of the contractile response to ET-1.
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ised by the initial area) rather than the non-normalisedD to prevent the
inﬂuence of the signiﬁcant geometry differences between the normal
and diseased groups.
Finite element modelling of artery ET-1 responses
Two-dimensional FE models that had the geometries of idealised
normal and atherosclerotic artery rings were created. The normal artery
model contained two separated regions of adventitia and media
(Fig. 1C), with diameter and wall thickness estimated from the arterial
rings used in the tensile ring experiments. Both of these regions were
assigned with the previously derived mean values of hyperelastic μ
andα determined for normal arterywall. Themedial layer was assigned
with an additional thermal expansion property to model the muscle
force generation in response to addition of ET-1 under isometric condi-
tions, where applied temperature in the model represents the applied
concentration of ET-1 used in the contraction experiments. The thermal
expansion property wasmodelled with an error function (erf) (Eq. (3))
using a user subroutine to generate the reaction forces that match the
ET-1 contraction experiments:
ε ¼ P1 erf P2Tð Þ½ P3 ð3Þ
ε and T are the strain and applied temperature, respectively, and P1, P2,
and P3 are three parameters that were modiﬁed to generate the forces
that match the ET-1 contraction experiments.
The idea of this modelling approach is to use the thermal modelling
capability within the Abaqus FE software to represent directly the
contractile effect of ET-1. The relationship between thermal strain and
temperature represented in Eq. (3) should be interpreted directly as
the effect of ET-1 concentration T on the muscle contraction strain ε.
The value of P1 governs the maximum contractile response in the
muscle, while P2 and P3 control the shape of the curve representingthe relationship between contractile strain and ET-1 concentration. P2
determines the shift of the curve to left or right and P3 determines the
slope of the curve.
The model was ﬁrst applied with a pre-stretch load (25 mN) that
corresponded to the mean basal force determined by the normalisation
procedure in the contraction studies in normal arteries. Thermal load-
ings of the same magnitudes of the administered ET-1 concentrations
were then applied. The results of the model were compared to those
of the ET-1 contraction experiment and an errorminimisation approach
was performed usingMATLAB to change the three parameters of Eq. (3)
with multiple iterations until a minimum average difference was
achieved.
Themodel of the atherosclerotic artery ringwas then created, which
contained an additional layer of plaque (Fig. 1D), the size of which was
estimated from the atherosclerotic samples used in the tensile ring ex-
periments. The adventitia and media were again modelled with the
same properties as those of the normal arterymodel. The plaque region
was assignedwith hyperelastic μ andα determined from the atheroscle-
rotic artery tensile tests. A pre-stretch load (36 mN) was applied,
derived from the normalised basal force determined in the contraction
study in diseased arteries, and the same thermal loadings were applied
to the diseased artery model. The reaction forces were then matched
with the contractile responses to ET-1 using a MATLAB error
minimisation approach by modifying the P1, P2, and P3 thermal param-
eters of the atherosclerotic model.
The atherosclerosis-induced changes of arterial contraction
under physiological condition were then examined by applying in-
ternal pressures of 80 mm Hg and 120 mm Hg to both normal and
atherosclerotic models, along with a thermal loading of 3 × 10−7 K
(equivalent to 3 × 10−7 M ET-1). The distensibility D of each model
was then calculated using Eq. (2), and comparisons were made
between the cases of without applying muscle contraction (passive),
applying the determined normal muscle tone to both models, and
applying diseased muscle tone to the diseased model.
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ET-1 mediated contractile responses in normal and atherosclerotic human
coronary artery
Optimised basal forces were signiﬁcantly different in normal
(25 ± 2 mN) and diseased (36 ± 3 mN) coronary artery. ET-1
contracted normal (pD2 = 8.03 ± 0.06, n= 68) and diseased (pD2 =
7.98± 0.06, n=55) coronary arterywith comparable potency. Absolute
maximum responses to ET-1 were signiﬁcantly greater in normal (EMAX
38±2mN) than in diseased (27±3mN) artery (Fig. 2A) butwhen nor-
malised to the terminal KCl response no difference in maximum
response to ET-1 in the two groups was obtained (normal, EMAX 78 ±
2% KCl; CAD, EMAX 76 ± 2% KCl) (Fig. 2B), indicating that the reduced
response to ET-1 most likely reﬂected a generalised decrease in contrac-
tility of the atherosclerotic tissue rather than an ET-1 speciﬁc effect.Passive mechanical properties of normal and atherosclerotic
coronary artery
Passive tensile ring test data showing the force–stretch relationship
for normal and diseased artery samples are shown in Fig. 2C. Matching
the force–stretch results of the normal artery FE models with those of
the tensile ring tests resulted in mean hyperelastic shear modulus μ=
2004 ± 410 Pa and hardening exponent α= 22.8 ± 2.2 for the vessel
wall of normal artery. These values were applied to the wall regions of
the atherosclerotic FE models, resulting in values for the plaque region
of μ= 2464 ± 1075 Pa and α= 38.3 ± 6.7. The mean distensibility D
of the normal and diseased artery samples derived from the FE models
were 1.12 ± 0.11 × 10−3 mmHg−1 and 0.87 ± 0.18 × 10−3 mmHg−1
respectively, indicating a trend for the normal artery wall to exhibit
greater distensibility than the diseased vessels.Finite elementmodelling of the ET-1 response in normal and atherosclerotic
coronary artery
The FE models of the normal and atherosclerotic arteries applied
with pre-stretch forces and thermal loadings are shown in Fig. 3A and
B. The optimum matching of the reaction forces between the ET-1
experiments and the normal (Fig. 3A) and diseased (Fig. 3B) FE models
resulted in parameters of the thermal property of the normal artery
model of P1 = −0.086, P2 = 2.6 × 107 K−1, and P3 = 0.34, whereas
those of the atherosclerotic artery model were P1 = −0.273, P2 =
3.6 × 107 K−1, and P3= 0.20. The negative values of P1 for bothmodels
resulted in the contraction of artery rings in response to ET-1. The
highermagnitude of P1 required for the atherosclerotic arterymodel in-
dicated that themaximumstrain associatedwith the drug responsewas
greater in the diseased than in the normal arteries. This suggests that-11 -10 -9
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Fig. 2. (A) Contractile responses to ET-1 inhistologically normal (●) anddiseased (■CAD) coron
KCl in each vessel ring. (C) Passive tensile ring test data showing the force–stretch relationshipsmooth muscle cells of the diseased arteries generate more force per
cell to ET-1 than those of the normal arteries.
The distensibility D of these two models under the physiological
condition without applying contractile muscle tone (passive) and
applying healthy or diseased muscle tones was determined from the
modelling of the ET-1 response (Table 1). The diseased model had a
lower D than the normal model in the passive condition, as previously
obtained in themodelling of the tensile ring tests. Applying the diseased
muscle tone signiﬁcantly increased D for the diseased model, which
achieved a similar level as that of the normalmodel with normalmuscle
tone.Discussion
Medial contractile smooth muscle atrophy and proliferation of non-
contractile intimal smooth muscle are hallmarks of human atheroscle-
rosis. We hypothesised that these changes would contribute to a
marked loss of contractile response to ET-1 in isolated rings of human
diseased coronary artery compared to histologically normal artery.
However, although we found a signiﬁcant reduction in the maximum
response to ET-1 in diseased artery, the response was still over 70% of
that in control arteries. The consequence of this maintained constrictor
response for patients may be that in vivo ET-1 produced locally in the
diseased vessel wall would produce focal vasospasm resulting in
profound reduction in coronary blood ﬂow owing to the already
compromised lumen. Variant angina, coronary vasospasm frequently
associated with atherosclerosis, can be life threatening but in a
recent case has been treated with bosentan implying that ET-
mediated vasoconstriction is a likely cause at least in some individuals
(Krishnan et al., 2010).
In human normal and atherosclerotic coronary artery in vitro we
have previously demonstrated that contractile responses to ET-1 are
mediated via the ETA receptor (Maguire and Davenport, 1998b, 2000).
We ﬁnd no increase in ET receptor density and no up-regulation of
ETB receptors in human atherosclerosis (Bacon et al., 1996) to explain
this maintained contractile response to ET-1 in disease and therefore
we investigated the passive mechanical properties of normal and
atherosclerotic coronary arteries using tensile ring tests and FE analysis.
Our data indicated that the diseased arteries were stiffer (i.e. exhibited
lower distensibility) than normal arteries, in agreement with previous
in vivo observations (van Popele et al., 2001; Wykretowicz et al.,
2009). Distensibility was chosen as the indicator of arterial stiffness
owing to its direct representation of the overall arterial compliance
and close correlation with the volume of blood ﬂow through the artery.
Elastic modulus, which is commonly used as a representation of
stiffness, varies across the plaque and arterial wall of the thickened
walled atherosclerotic artery (Beattie et al., 1998; Baldewsing et al.,
2008) and is therefore not an appropriate indicator of overall arterial
compliance. The distensibility in the passive condition is determined1.0 1.1 1.2 1.3 1.4
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428 C.Y. Ooi et al. / Life Sciences 118 (2014) 424–429by the material properties of the arterial wall, and future studies to
determine how changes in distensibility correlate to alterations in the
expression of, for example extracellularmatrix proteins, would be infor-
mative. Indeed, recently the ﬁrst layer-speciﬁc comparative proteomic
analyses of human atherosclerotic coronary intima and media have
been reported, which indicated changes in the intimal expression of ex-
tracellular matrix proteins collagen α-1 (IV) and microﬁbril-associated
glycoprotein 4 and in the markers of contractile phenotype, SM22α
and myosin regulatory light 2 (de la Cuesta et al., 2011). Whereas in
themedia therewas evidence for dysregulation of cytoskeleton proteins
consistent with the switch of medial smoothmuscle cells from contrac-
tile to synthetic phenotype, which may also explain the compression
and thinning of the medial layer in response to intimal thickening (de
la Cuesta et al., 2013).
The mechanisms of the arterial responses to ET-1 were demonstrat-
ed using FE models, where the diseased artery had similar, or slightly
lower, reaction forces when compared with the normal artery. The
maintained ability of diseased arteries to contract to ET-1 to a similar
extent as normal arteries, despite loss of smooth muscle, may result
from an increase of the reactivity of the remaining smooth muscle
cells to ET-1, as indicated in the FE modelling where the P1 parameter
(thermal reactivity) was higher in the atherosclerotic compared to
normal artery model. There may be an underestimate of the diseased
model P1, as medial thickness was kept the same in the FE normal and
diseased models for ease of comparison rather than reduced in the dis-
eased model to reﬂect medial atrophy. A limitation of this study is that
contractile responses have not been normalised to medial thickness;
however, this avoids any ambiguity in identifying the active medial
layer in the diseased artery that would introduce uncertainty into the
analysis. Therefore we predict that the magnitude of the contractile
response P1 for the diseased artery would be even higher if the medial
thickness of the atherosclerotic artery model were reduced, while the
force response was maintained.
Finally the physiological distensibility results of the normal and
atherosclerotic models with muscle tones suggest that the diseased
artery has an adaptation response which changes muscle reactivity to
increase the arterial contraction to applied ET-1, resulting in a distensi-
bility that is closer to that of the normal artery. The mechanisms
underlying this observation require further investigation.Table 1
Distensibility D of the normal and diseased atherosclerotic (CAD) models without
applying contractile muscle tone (passive) and applying normal or diseased muscle
tones determined from the modelling of the ET-1 response.
Artery D (mm Hg−1)
Passive Normal tone Diseased tone
Normal 1.10 × 10−3 1.08 × 10−3 –
CAD 0.67 × 10−3 0.67 × 10−3 1.04 × 10−3Conclusion
This study has identiﬁed a maintained active response of human
atherosclerotic artery to ET-1 in vitro despite extensive thinning of the
media smooth muscle layer. As well as providing comparisons of the
mechanical properties of the normal and diseased arteries, the tensile
tests and FE modelling demonstrated the potential elevated contractile
strains developed by diseased smooth muscle cells in response to ET-1.
These results suggest that adaptation mechanisms occur with the path-
ogenesis of atherosclerosis to maintain the distensibility of the diseased
vessel wall in response to vasoconstrictor such as ET-1. If ET-1 produc-
tion is increased in the atherosclerotic artery then themaintained ability
of the diseased artery wall to respond to this peptide may contribute to
local vasospasm that is associated with this disease.
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